2
Sep
2020
Tech Impact Requires Deep Engagement With Biopharma Lead Users
In today’s Wall Street Journal, I review The Innovation Delusion, a new book arguing that innovation is overrated and maintenance is underrated; moreover, the authors assert, we have magical thinking around innovation, and often view it as fairy dust that can be imported from Silicon Valley then sprinkled on ossifying organizations to revive and rejuvenate them. (Steve Blank discussed the... Read More
2
Sep
2020
Beyond AAV: AVROBIO and Orchard Take Ex Vivo Approach to Gene Therapy
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.